Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Abiomed Inc (NASDAQ: ABMD) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Abiomed Inc (NASDAQ: ABMD) concerning whether a series of statements by Abiomed Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On November 17, 2019, clinical studies were presented at the American Heart Association’s annual meeting in Philadelphia that presented data questioning the safety and effectiveness of Abiomed’s Impella heart pumps.

On this news, the price of NASDAQ: ABMD declined more than 20% on November 18, 2019.

Based in Danvers, Massachusetts, and founded in 1981 Abiomed Inc engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.

If you purchased shares of Abiomed Inc (NASDAQ: ABMD) on or before November 17, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185